Multidisciplinary Association for Psychedelic Studies

Institution (Education)

Homepage Wikipedia ROR

Also Known As

Multidisciplinary Association for Psychedelic Studies · Acronym: MAPS

420

Publications

35.2K

Citations

Authors

140

Concepts

About

Multidisciplinary Association for Psychedelic Studies is a education institution in Santa Cruz, United States known for social sciences, medicine, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	95	7.4K
2	Health Sciences	4	6	216
3	Education	2	6	184
4	Engineering	1	1	11
5	Humanities	1	3	69

Multidisciplinary Association for Psychedelic Studies

420

Publications

35.2K

Citations

Page 1

	Year	Citations
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study Jennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein, Nature Medicine	2021	895
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases Peter Gasser, Dominique Holstein, Yvonne Michel, The Journal of Nervous and Mental Disease Psychotropic MedicationState-trait Anxiety InventoryPsychopharmacologyMental HealthClinical Treatment	2014	725
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer, Journal of Psychopharmacology PsychotherapyPsychotropic MedicationPsychopharmacologyMental HealthOpen-label Mdma	2010	652
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial Michael C. Mithoefer, Ann T. Mithoefer, Allison A. Feduccia, The Lancet Psychiatry Psychiatric EvaluationPsychiatryAdult Behavioral HealthMedicineClinical Psychology	2018	426
Single-Dose Psilocybin Treatment for Major Depressive Disorder Charles L. Raison, Gerard Sanacora, Joshua Woolley, JAMA	2023	423
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer, Journal of Psychopharmacology	2012	367
RETRACTED ARTICLE: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials Michael C. Mithoefer, Allison A. Feduccia, Lisa Jerome, Psychopharmacology	2019	357
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial Jennifer Mitchell, Marcela Ot’alora G., Bessel van der Kolk, Nature Medicine	2023	340
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Journal of Psychopharmacology	2020	330
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study Alicia Danforth, Charles S. Grob, Christopher M. Struble, Psychopharmacology	2018	270

Page 1